TLRY Tilray Inc

Price (delayed)

$17.20

Market cap

$2.95B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.15

Enterprise value

$3.07B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, ...

Highlights

Tilray's gross margin has soared by 183% YoY and by 149% from the previous quarter
Tilray's gross profit has soared by 152% from the previous quarter
Tilray's quick ratio has decreased by 16% YoY and by 10% from the previous quarter

Key stats

What are the main financial stats of TLRY
Market
Shares outstanding
171.76M
Market cap
$2.95B
Enterprise value
$3.07B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.14
Price to sales (P/S)
10.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.59
Earnings
Revenue
$210.48M
EBIT
-$237.46M
EBITDA
-$218.8M
Free cash flow
-$171.33M
Per share
EPS
-$2.15
Free cash flow per share
-$1.36
Book value per share
$2.8
Revenue per share
$1.67
TBVPS
$4.7
Balance sheet
Total assets
$945.95M
Total liabilities
$572.05M
Debt
$306.26M
Equity
$373.9M
Working capital
$165.74M
Liquidity
Debt to equity
0.82
Current ratio
1.91
Quick ratio
1.21
Net debt/EBITDA
-0.53
Margins
EBITDA margin
-104%
Gross margin
11.7%
Net margin
-128.8%
Operating margin
-92.7%
Efficiency
Return on assets
-30.1%
Return on equity
-122.9%
Return on invested capital
-35.5%
Return on capital employed
-31.1%
Return on sales
-112.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TLRY stock price

How has the Tilray stock price performed over time
Intraday
0%
1 week
0.06%
1 month
-32.15%
1 year
164.62%
YTD
108.23%
QTD
-24.33%

Financial performance

How have Tilray's revenue and profit performed over time
Revenue
$210.48M
Gross profit
$24.66M
Operating income
-$195.14M
Net income
-$271.07M
Gross margin
11.7%
Net margin
-128.8%
Tilray's gross margin has soared by 183% YoY and by 149% from the previous quarter
Tilray's gross profit has soared by 152% from the previous quarter
The operating margin has soared by 52% from the previous quarter and by 48% YoY
The operating income has surged by 50% since the previous quarter and by 35% year-on-year

Growth

What is Tilray's growth rate over time

Valuation

What is Tilray stock price valuation
P/E
N/A
P/B
6.14
P/S
10.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.59
The EPS has soared by 53% since the previous quarter and by 33% year-on-year
TLRY's equity has soared by 100% since the previous quarter and by 31% year-on-year
The price to book (P/B) is 46% higher than the last 4 quarters average of 4.2
TLRY's price to sales (P/S) is 151% more than its last 4 quarters average of 4.1
TLRY's revenue is up by 26% year-on-year and by 4.8% since the previous quarter

Efficiency

How efficient is Tilray business performance
The company's return on equity rose by 50% QoQ but it fell by 38% YoY
The ROS has soared by 50% since the previous quarter and by 36% year-on-year
The company's return on assets rose by 45% QoQ and by 5% YoY
The ROIC has grown by 44% from the previous quarter and by 21% YoY

Dividends

What is TLRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLRY.

Financial health

How did Tilray financials performed over time
Tilray's total assets is 65% higher than its total liabilities
Tilray's current ratio has decreased by 32% YoY and by 16% QoQ
The total liabilities has contracted by 18% from the previous quarter and by 6% YoY
The debt is 18% less than the equity
TLRY's equity has soared by 100% since the previous quarter and by 31% year-on-year
Tilray's debt to equity has shrunk by 68% QoQ and by 46% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.